By Jennifer Valli, Published in the Memphis Flyer
Is there a magic pill? Addressing Low Sexual Desire in Women
The FDA has approved 26 sex-related drugs and treatments for men. Finally, women get one for themselves. But does it work?
As a psychotherapist who specializes in sexual health, I work with couples and individuals to improve their emotional and physical intimacy, and I have been asked this question since the announcement of “the female Viagra” Flibanserin, or Addyi. This drug, however, works very differently than Viagra, which treats dysfunction by increasing blood flow to the genitals. Addyi, in contrast, works on neurotransmitters in the frontal cortex in the brain, increasing desire and decreasing sexual inhibition.
So what is the drug’s effectiveness? According to the FDA, only 8-13% of the subjects were helped by the drug, reporting an average of one more sexual experience a month compared to placebo. Some medical groups felt like the benefits of the medicine didn’t outweigh its side effects, as it may cause low blood pressure and loss of consciousness, especially if consumed in combination with alcohol. Others advocated strongly for the drug, seeing the lack of FDA-approved drugs for women as an issue of inequality.
As I have often seen in my practice, sexual response is often misunderstood and therefore women may be inaccurately seen as dysfunctional. Female response is complex and related to a variety of factors that may impact desire. Many times, women are motivated to be intimate from an intellectual space, wishing to connect with their partners, but as they proceed they feel physically aroused in the process.
A woman can feel shame when she doesn’t feel overcome with desire prior to sex and many hormone clinics capitalize on this anxiety. Addyi is also trying to elicit desire on the front end, a response more likely to be consistent with more males than females, but one that can vary between people and even within one person from experience to experience.
Many women will be willing to take this pill despite its side effects, but hopefully they will address the other factors that impact desire. For example, some women experience larger barriers to connecting related to past infidelity, or other difficult relationship dynamics. One out of four women prior to age 18 has had some past sexual trauma and that plays into how they see themselves as a sexual person.
Many women aren’t comfortable with body image and this directly affects their desire and ability to orgasm. A University of Texas study showed that 70% of women cover some part of their bodies during sexual activity, rather than tuning into the moment, and researcher Thomas Cash found that body image impacted how women experience sex itself. Body-conscious women reported experiencing orgasms 42% of the time, compared to body-confident women who experienced orgasms 73% of the time. The insecurity about body image doesn’t stop there – common irrational fears of women include thinking that their genitals may not look or smell normal. This is yet another thing that impacts desire; we each need to feel comfortable when connecting intimately.
Often couples present with a desire discrepancy where one person’s drive is higher than the other’s. The lower drive person is labeled “the problem”, while the higher drive partner is labeled the “sex addict”. But are they really an addict? Do they have a history of substance use, gambling or any other addictive behaviors, or is it just that he or she has a stronger sex drive? This asymmetry can create resentment with the higher drive partner feeling rejected after initiating sex fails repeatedly, and the lower desire partner feeling used. If the couple is still waiting for that initial desire in the woman to kick in, she will likely see sex as a task. All of this results in both partners feeling angry and resentful, and certainly hoping there is a medicine to fix all of this. Sex offers a powerful, non-verbal way of communicating. The question remains, do women need a medicine to achieve what is a normal sexual response?
Have drug companies had trouble creating a successful drug because desire in women is a complex issue or do companies spend less money on women, as a more marginalized population? Certainly we are less comfortable thinking about sexuality in women compared to men. Seeing ourselves as sexual is deeply rooted in religion and culture, and taking a pill isn’t going to override that. Women may take the pill, wait for it to work, and then feel more inadequate when they don’t feel overcome with desire. With or without the pill, those individuals and couples who examine sexuality in depth and continue to engage regularly despite hiccups will enjoy quality intimate interactions.
*information protected by copyright